Session 2: Impact of Genetic Evolution and Cancer-Associated Neuroinflammation on Disease Course

SESSION CHAIR: Emery Haley

12:50 p.m.
Hypothalamic mechanisms in cancer cachexia
Daniel L. Marks M.D., Ph.D. – Oregon Health and Science University

1:20 p.m.
Selection vs. mechanistic biases in determining rates of arm-level copy-number alterations in cancer    
Rameen Beroukhim, M.D., Ph.D. – Dana-Farber Cancer Institute and Harvard Medical School

1:50 p.m.       
Continued discussion – Drs. Marks and Beroukhim